Skip to main content
Panacea Biotec Ltd. logo

Panacea Biotec Ltd. — Investor Relations & Filings

Ticker · PANACEABIO ISIN · INE922B01023 LEI · 3358001FA81ZQYDLO796 BSE.NS Manufacturing
Open in API
Filings indexed 794 across all filing types
Latest filing 2020-12-18 Capital/Financing Update
Country IN India
Listing BSE.NS PANACEABIO

About Panacea Biotec Ltd.

https://www.panaceabiotec.com

Panacea Biotec Ltd. is a research-driven health management company specializing in the development, manufacturing, and marketing of vaccines, biopharmaceuticals, and pharmaceutical formulations. The organization focuses on therapeutic segments including organ transplantation, nephrology, oncology, diabetes, and pain management. Its vaccine portfolio supports global immunization initiatives, addressing diseases such as polio and hepatitis B through partnerships with international health agencies. The company operates integrated research and development centers and manufacturing facilities that adhere to international quality standards. Panacea Biotec emphasizes the creation of innovative drug delivery systems and complex generics to improve patient outcomes. Its operations are characterized by a commitment to biotechnology-led medical solutions and the production of affordable, high-quality therapeutic products for diverse global markets.

Recent filings

Filing Released Lang Actions
Updates
Capital/Financing Update Classification · 95% confidence The document is an official communication regarding the listing of equity shares of Ravinder Heights Limited pursuant to a Scheme of Arrangement involving Panacea Biotec Limited. It includes references to regulatory approvals, stock exchange notifications, and details about share allotment and listing dates. The content is primarily about the admission of shares to trading on stock exchanges and related procedural information. There are no financial statements, audit opinions, management discussions, or earnings data presented. The document is a formal announcement of a capital market event (listing of shares) following a corporate restructuring (demerger). Therefore, it fits best under the category of Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes such as share listings after a scheme of arrangement.
2020-12-18 English
Related Party Transactions
Regulatory Filings Classification · 95% confidence The document is a disclosure under Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It provides detailed related party transactions for the half year ended September 30, 2020, on a consolidated basis. The content includes names of related parties, key management personnel, and detailed financial transactions and balances with these related parties. This type of disclosure is typically part of regulatory compliance filings related to financial reporting but is not a full financial report like an annual or interim report. It is a specific regulatory disclosure about related party transactions, which is a common requirement under listing obligations. The document is substantive and contains detailed financial data related to related party transactions, not just an announcement or certification. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement and compliance document that does not fit other specific categories like Annual Report or Interim Report.
2020-12-11 English
Updates
Regulatory Filings
2020-12-07 English
Copy of Newspaper Publication
AGM Information Classification · 95% confidence The document is a letter addressed to stock exchanges (NSE and BSE) regarding compliance under Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It mentions enclosing newspaper advertisements about Notice of AGM, Cut-off Date, Remote E-voting Information, and Book Closure published in newspapers. The content is primarily an announcement of compliance and publication of notices related to the Annual General Meeting (AGM), not the AGM report or materials themselves. The document length is about 15,000 characters, but the content is a formal notification of the AGM notice publication, not the AGM presentation or materials. Therefore, it fits best under AGM Information (AGM-R) as it relates to AGM notices and information dissemination rather than the full AGM report or minutes.
2020-12-04 English
Spurt in Volume
Regulatory Filings Classification · 100% confidence The document text is extremely short (64 characters) and contains no substantive content, only a placeholder for an omitted picture. There is no financial data, report content, or any detailed information. Given the lack of content, this cannot be classified as a full report or detailed filing. It is best classified as a Regulatory Filing (RNS) as a fallback category for miscellaneous filings that do not fit other categories.
2020-12-03 English
Shareholders meeting
AGM Information Classification · 100% confidence The document is a detailed notice for the Thirty Sixth Annual General Meeting (AGM) of Panacea Biotec Limited, including the agenda items such as adoption of audited financial statements, appointment and re-appointment of directors, ratification of auditor remuneration, and procedural details for electronic voting. It explicitly states it is a Notice of AGM and includes instructions for members regarding the meeting conducted via video conferencing due to COVID-19. The document does not contain the actual financial statements or reports but refers to their adoption at the meeting. It also mentions the dispatch of the Annual Report electronically but does not include the report itself. Therefore, this document is a Notice of Annual General Meeting, which falls under the category of AGM Information (AGM-R).
2020-12-02 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.